417 related articles for article (PubMed ID: 25038434)
41. The antithrombotic effect of RSNK in blood-stasis model rats.
Dang X; Miao JJ; Chen AQ; Li P; Chen L; Liang JR; Xie RM; Zhao Y
J Ethnopharmacol; 2015 Sep; 173():266-72. PubMed ID: 26216512
[TBL] [Abstract][Full Text] [Related]
42. In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase.
Xu M; Hao H; Jiang L; Long F; Wei Y; Ji H; Sun B; Peng Y; Wang G; Ju W; Li P
Phytomedicine; 2015 Apr; 22(4):444-51. PubMed ID: 25925966
[TBL] [Abstract][Full Text] [Related]
43. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis.
Lee JJ; Jin YR; Lee JH; Yu JY; Han XH; Oh KW; Hong JT; Kim TJ; Yun YP
Planta Med; 2007 Feb; 73(2):121-7. PubMed ID: 17410649
[TBL] [Abstract][Full Text] [Related]
44. The cardioprotective effects of marrubiin, a diterpenoid found in Leonotis leonurus extracts.
Mnonopi N; Levendal RA; Davies-Coleman MT; Frost CL
J Ethnopharmacol; 2011 Oct; 138(1):67-75. PubMed ID: 21893184
[TBL] [Abstract][Full Text] [Related]
45. Tanshinone II A, a multiple target neuroprotectant, promotes caveolae-dependent neuronal differentiation.
Zhao Y; Xu P; Hu S; Du L; Xu Z; Zhang H; Cui W; Mak S; Xu D; Shen J; Han Y; Liu Y; Xue M
Eur J Pharmacol; 2015 Oct; 765():437-46. PubMed ID: 26363255
[TBL] [Abstract][Full Text] [Related]
46. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
[TBL] [Abstract][Full Text] [Related]
47. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells.
Yang LJ; Jeng CJ; Kung HN; Chang CC; Wang AG; Chau GY; Don MJ; Chau YP
J Biomed Sci; 2005; 12(2):347-61. PubMed ID: 15917998
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation.
Thisoda P; Rangkadilok N; Pholphana N; Worasuttayangkurn L; Ruchirawat S; Satayavivad J
Eur J Pharmacol; 2006 Dec; 553(1-3):39-45. PubMed ID: 17081514
[TBL] [Abstract][Full Text] [Related]
49. Atractylodes lactone compounds inhibit platelet activation.
Chen Y; Yang W; Guo L; Wu X; Zhang T; Liu J; Zhang J
Platelets; 2017 Mar; 28(2):194-202. PubMed ID: 27560602
[TBL] [Abstract][Full Text] [Related]
50. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
[TBL] [Abstract][Full Text] [Related]
51. A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza - Ligusticum chuanxiong as an example.
Zhang DY; Peng RQ; Wang X; Zuo HL; Lyu LY; Yang FQ; Hu YJ
J Ethnopharmacol; 2022 Jun; 292():115197. PubMed ID: 35331879
[TBL] [Abstract][Full Text] [Related]
52. Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone.
Seo EJ; Lee DU; Kwak JH; Lee SM; Kim YS; Jung YS
J Ethnopharmacol; 2011 Apr; 135(1):48-54. PubMed ID: 21354294
[TBL] [Abstract][Full Text] [Related]
53. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
[TBL] [Abstract][Full Text] [Related]
54. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
55. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents.
Zheng L; Liu M; Wei M; Liu Y; Dong M; Luo Y; Zhao P; Dong H; Niu W; Yan Z; Li Z
Respir Physiol Neurobiol; 2015 Jan; 205():120-8. PubMed ID: 25305099
[TBL] [Abstract][Full Text] [Related]
56. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
57. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
58. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
[TBL] [Abstract][Full Text] [Related]
59. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.
Liu X; Ye M; An C; Pan L; Ji L
Biomaterials; 2013 Sep; 34(28):6893-905. PubMed ID: 23768781
[TBL] [Abstract][Full Text] [Related]
60. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
